healthcare
- Home
- healthcare
Public
Research Note - Rise of the Cashless Economy
- Review
- June 3, 2020
Novatti launches new payments platform for purpose-issued Visa cards
- Review
- September 29, 2020
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
Quickfire FDA approval for Acrux’s testosterone sends share price soaring
Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted for their generic equivalent of a common testosterone topical solution which generates more than $25 million annually. Approval was granted from the Food and Drug administration for Acrux’s gel following their submission in August 2018
Read MorePublic
Never been Healthia: COVID-19 spurs a new breed of patient
Is the notion of the typical Australian stacking on the ‘isobars’ and indulging in a few too many ‘lockdown lagers’ during their in-house detention just another case of fake news? In reality, says Healthia (ASX: HLA) CEO Wesley Coote, incarcerated citizens were more likely to be exercising more often and assiduously holding to their appointments
Read MorePublic
NGS making US push, secures 1,000 sales reps to promote their pediatric growth products
Pediatric healthcare company Nutritional Growth Solutions (ASX: NGS) is set to significantly increase their exposure to the lucrative US healthcare products market, securing a distribution agreement that will see more than 1,000 sales representatives begin pushing NGS products. The agreement is with leading US medical distributor cooperative IMCO, INC which distributes healthcare products through home
Read MorePublic
This app just beat 98% of dermatologists and MyFiziq are buying in
Artificial intelligence continues to emerge as the driving force behind healthcare and when pitted against 157 actual human dermatologists, this technology beat 98% of them in a diagnosis test. It’s why healthtech company MyFiziq (ASX: MYQ) is integrating it into their app. The tech itself is developed by Canadian company Triage Technology and can identify
Read MorePublic
Shareholders support Healthia with $13.2m for expansion into optometry
Healthia (ASX: HLA) shareholders have voted with their wallets firmly in favour of the allied healthcare provider’s expansion into optometry with the Company successfully raising $13.2m from an Entitlement Offer to fund their acquisition of The Optical Company (TOC). The $13.2m from shareholders forms part of the $43m acquisition to proceed, adding 41 optometry clinics
Read MorePublic
Healthia rising as leading healthcare operater with optometry expansion
Leading allied healthcare company Healthia (ASX: HLA) is set to significantly increase their services and national footprint with the $43 million acquisition of optometry group The Optical Company and their 41 clinics. The acquisition is a horizontal expansion for Healthia which has primarily operated in the podiatry and physiotherapy sectors while also owning iOrthotics, Australia’s
Read MorePublic